Back to HomeBeta

ICD-10 Coding for Metastatic Pancreatic Cancer(C25.9, C78.89)

Complete ICD-10-CM coding and documentation guide for Metastatic Pancreatic Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Pancreatic Cancer with MetastasisSecondary Pancreatic Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Pancreatic Cancer

C25-C26Primary Range

Malignant neoplasms of pancreas

This range includes primary pancreatic cancer codes, essential for identifying the origin of metastatic disease.

Secondary malignant neoplasms

This range covers codes for secondary sites of metastasis, crucial for documenting the spread of pancreatic cancer.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C25.9Malignant neoplasm of pancreas, unspecifiedUse when the primary site of pancreatic cancer is unspecified or generalized.
  • Imaging-confirmed pancreatic mass
  • Biopsy results confirming adenocarcinoma
C78.89Secondary malignant neoplasm of other specified sitesUse when documenting metastasis from pancreatic cancer to other specified sites.
  • Biopsy-proven metastasis to a distant site
  • Imaging showing metastatic lesions

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for metastatic pancreatic cancer

Essential facts and insights about Metastatic Pancreatic Cancer

Metastatic pancreatic cancer is coded with C25.x for the primary site and C78.x for secondary sites, based on treatment focus.

Primary ICD-10-CM Codes for metastatic pancreatic cancer

Malignant neoplasm of pancreas, unspecified
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed pancreatic mass with malignant features

Applicable To

  • Primary pancreatic cancer

Excludes

  • Benign pancreatic neoplasm

Clinical Validation Requirements

  • Imaging-confirmed pancreatic mass
  • Biopsy results confirming adenocarcinoma

Code-Specific Risks

  • Risk of under-documenting specific site within the pancreas

Coding Notes

  • Ensure documentation specifies malignancy to avoid confusion with benign conditions.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use for visits primarily for chemotherapy administration.

Secondary malignant neoplasm of liver

C78.7
Use for liver metastasis from pancreatic cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Benign neoplasm of pancreas

D13.6
Use D13.6 for benign lesions; C25.9 requires malignancy confirmation.

Malignant neoplasm without specification of site

C80.1
Use C80.1 when primary site is unknown; C78.89 requires known primary.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Metastatic Pancreatic Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C25.9.

Impact

Clinical: Misrepresentation of active disease status., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement for active treatment.

Mitigation Strategy

Verify treatment status before coding., Use active codes until treatment concludes.

Impact

Reimbursement: Incorrect DRG assignment, affecting reimbursement., Compliance: Non-compliance with ICD-10 sequencing rules., Data Quality: Inaccurate data on cancer treatment focus.

Mitigation Strategy

Sequence secondary code first if treatment focus is on metastasis.

Impact

Using unspecified codes when primary site is known.

Mitigation Strategy

Ensure documentation specifies primary site whenever possible.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Metastatic Pancreatic Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Metastatic Pancreatic Cancer

Use these documentation templates to ensure complete and accurate documentation for Metastatic Pancreatic Cancer. These templates include all required elements for proper coding and billing.

Metastatic pancreatic cancer with liver metastasis

Specialty: Oncology

Required Elements

  • Primary site documentation
  • Metastatic site details
  • Treatment plan

Example Documentation

Assessment: Metastatic pancreatic adenocarcinoma to liver. Plan: Initiate FOLFIRINOX.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Pancreatic cancer with spread.
Good Documentation Example
Metastatic pancreatic adenocarcinoma to liver, confirmed by biopsy.
Explanation
The good example specifies the metastatic site and confirms diagnosis with biopsy.

Need help with ICD-10 coding for Metastatic Pancreatic Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more